Published in Am J Clin Nutr on November 02, 2016
Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem (1972) 95.79
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation (2002) 76.93
Heart disease and stroke statistics--2015 update: a report from the American Heart Association. Circulation (2014) 22.74
Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol (2000) 4.83
Cross sectional study of effects of drinking green tea on cardiovascular and liver diseases. BMJ (1995) 1.97
The major green tea polyphenol, (-)-epigallocatechin-3-gallate, inhibits obesity, metabolic syndrome, and fatty liver disease in high-fat-fed mice. J Nutr (2008) 1.82
Association between green tea intake and coronary artery disease in a Chinese population. Circ J (2009) 1.54
A green tea extract high in catechins reduces body fat and cardiovascular risks in humans. Obesity (Silver Spring) (2007) 1.50
Preventive effects of drinking green tea on cancer and cardiovascular disease: epidemiological evidence for multiple targeting prevention. Biofactors (2000) 1.43
Effect of EGCG on lipid absorption and plasma lipid levels in rats. J Nutr Biochem (2003) 1.41
Deaths: Leading Causes for 2014. Natl Vital Stat Rep (2016) 1.40
Green tea supplementation affects body weight, lipids, and lipid peroxidation in obese subjects with metabolic syndrome. J Am Coll Nutr (2010) 1.31
Effects of dietary supplementation with the green tea polyphenol epigallocatechin-3-gallate on insulin resistance and associated metabolic risk factors: randomized controlled trial. Br J Nutr (2008) 1.28
Green tea extract reduces blood pressure, inflammatory biomarkers, and oxidative stress and improves parameters associated with insulin resistance in obese, hypertensive patients. Nutr Res (2012) 1.23
Effect of green tea extract on obese women: a randomized, double-blind, placebo-controlled clinical trial. Clin Nutr (2008) 1.22
Effectiveness of moderate green tea consumption on antioxidative status and plasma lipid profile in humans. J Nutr Biochem (2005) 1.13
Green tea intake lowers fasting serum total and LDL cholesterol in adults: a meta-analysis of 14 randomized controlled trials. Am J Clin Nutr (2011) 1.06
Randomized controlled trial for an effect of green tea-extract powder supplementation on glucose abnormalities. Eur J Clin Nutr (2007) 1.05
Effects of green tea supplementation on elements, total antioxidants, lipids, and glucose values in the serum of obese patients. Biol Trace Elem Res (2012) 1.03
Effect of 2-month controlled green tea intervention on lipoprotein cholesterol, glucose, and hormone levels in healthy postmenopausal women. Cancer Prev Res (Phila) (2012) 1.02
Genetic Association Between the COMT Genotype and Urinary Levels of Tea Polyphenols and Their Metabolites among Daily Green Tea Drinkers. Int J Mol Epidemiol Genet (2010) 1.01
Does supplementation with green tea extract improve insulin resistance in obese type 2 diabetics? A randomized, double-blind, and placebo-controlled clinical trial. Altern Med Rev (2011) 1.01
Estimating the long-term effects of storage at -70 degrees C on cholesterol, triglyceride, and HDL-cholesterol measurements in stored sera. Clin Chem (2000) 1.01
Chinese green tea lowers cholesterol level through an increase in fecal lipid excretion. Life Sci (2000) 1.00
Epigallocatechin-3-gallate potently inhibits the in vitro activity of hydroxy-3-methyl-glutaryl-CoA reductase. J Lipid Res (2011) 0.99
Effects of tea polyphenols on emulsification of olive oil in a small intestine model system. J Agric Food Chem (2006) 0.99
Green tea catechin consumption enhances exercise-induced abdominal fat loss in overweight and obese adults. J Nutr (2008) 0.99
Can EGCG reduce abdominal fat in obese subjects? J Am Coll Nutr (2007) 0.98
Green tea catechins decrease total and low-density lipoprotein cholesterol: a systematic review and meta-analysis. J Am Diet Assoc (2011) 0.98
Green tea consumption and serum lipids and lipoproteins in a population of healthy workers in Japan. Ann Epidemiol (2002) 0.97
Green tea improves metabolic biomarkers, not weight or body composition: a pilot study in overweight breast cancer survivors. J Hum Nutr Diet (2010) 0.95
Catechin safely improved higher levels of fatness, blood pressure, and cholesterol in children. Obesity (Silver Spring) (2008) 0.95
Standardized capsule of Camellia sinensis lowers cardiovascular risk factors in a randomized, double-blind, placebo-controlled study. Nutrition (2008) 0.95
Intra-individual variation of serum cholesterol, triglycerides and high density lipoprotein cholesterol in normal humans. Atherosclerosis (1982) 0.94
Health effects of green tea catechins in overweight and obese men: a randomised controlled cross-over trial. Br J Nutr (2011) 0.94
Green tea consumption and serum lipid profiles: a cross-sectional study in northern Kyushu, Japan. Prev Med (1992) 0.93
Tea consumption and ischemic stroke risk: a case-control study in southern China. Stroke (2009) 0.91
Effect of green tea (Camellia sinensis) consumption on the components of metabolic syndrome in elderly. J Nutr Health Aging (2012) 0.91
Daily consumption of an aqueous green tea extract supplement does not impair liver function or alter cardiovascular disease risk biomarkers in healthy men. J Nutr (2008) 0.90
Metabolic effects of green tea and of phases of weight loss. Physiol Behav (2005) 0.89
Lipoproteins and BMI: a comparison between women during transition to menopause and regularly menstruating healthy women. Maturitas (2002) 0.89
No effect of consumption of green and black tea on plasma lipid and antioxidant levels and on LDL oxidation in smokers. Arterioscler Thromb Vasc Biol (1998) 0.87
A green tea catechin extract upregulates the hepatic low-density lipoprotein receptor in rats. Lipids (2007) 0.86
The effect of green tea on blood pressure and lipid profile: a systematic review and meta-analysis of randomized clinical trials. Nutr Metab Cardiovasc Dis (2014) 0.86
Association of green tea consumption with risk of coronary heart disease in Chinese population. Int J Cardiol (2014) 0.84
The safety of green tea extract supplementation in postmenopausal women at risk for breast cancer: results of the Minnesota Green Tea Trial. Food Chem Toxicol (2015) 0.82
Relation of green tea consumption to serum lipids and lipoproteins in Japanese men. J Epidemiol (1996) 0.82
The Minnesota Green Tea Trial (MGTT), a randomized controlled trial of the efficacy of green tea extract on biomarkers of breast cancer risk: study rationale, design, methods, and participant characteristics. Cancer Causes Control (2015) 0.81
Green tea catechins and blood pressure: a systematic review and meta-analysis of randomised controlled trials. Eur J Nutr (2014) 0.81
Prospective double-blind crossover study of Camellia sinensis (green tea) in dyslipidemias. Arq Bras Cardiol (2009) 0.79
Randomized controlled trial for an effect of catechin-enriched green tea consumption on adiponectin and cardiovascular disease risk factors. Food Nutr Res (2011) 0.79
Mechanistic studies for tri-targeted inhibition of enzymes involved in cholesterol biosynthesis by green tea polyphenols. Org Biomol Chem (2014) 0.78
Association between soy and green tea (Camellia sinensis) diminishes hypercholesterolemia and increases total plasma antioxidant potential in dyslipidemic subjects. Nutrition (2008) 0.78
Minor effects of green tea catechin supplementation on cardiovascular risk markers in active older people: a randomized controlled trial. Geriatr Gerontol Int (2012) 0.77
Genetic determinants of cytochrome P450 2A6 activity and biomarkers of tobacco smoke exposure in relation to risk of lung cancer development in the Shanghai cohort study. Int J Cancer (2016) 0.82
Reproductive factors, hormone use and gastric cancer risk: The Singapore Chinese Health Study. Int J Cancer (2016) 0.77
Soluble levels of CD27 and CD30 are associated with risk of non-Hodgkin lymphoma in three Chinese prospective cohorts. Int J Cancer (2015) 0.76
Circulating concentrations of biomarkers and metabolites related to vitamin status, one-carbon and the kynurenine pathways in US, Nordic, Asian, and Australian populations. Am J Clin Nutr (2017) 0.75
A splicing variant of TERT identified by GWAS interacts with menopausal estrogen therapy in risk of ovarian cancer. Int J Cancer (2016) 0.75